Old Web
English
Sign In
Acemap
>
Paper
>
A Pilot Study of the Anti-SLAMF7 Monoclonal Antibody, Elotuzumab, in Myelofibrosis
A Pilot Study of the Anti-SLAMF7 Monoclonal Antibody, Elotuzumab, in Myelofibrosis
2021
Prithviraj Bose
Taghi Manshouri
Sharon D. Bledsoe
Nitin Jain
Lucia Masarova
Naveen Pemmaraju
Nakiuda Hall
Mary Ann Richie
Xuemei Wang
Hagop M. Kantarjian
Zeev Estrov
Srdan Verstovsek
Keywords:
Cancer research
Elotuzumab
Myelofibrosis
Monoclonal antibody
Medicine
SLAMF7
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]